Doctor Alvaro Santana Garrido

Karolinska Institute, Stockholm (Sweden)

Follow

Contributor content

BUD13 as a novel mediator of vascular endothelial dysfunction associated with type 2 diabetes

Presentation

BUD13 as a novel mediator of vascular endothelial dysfunction associated with type 2 diabetes

ESC 365 is supported by

novartis

Explore sponsored resources